New research suggests that older women who complain of memory problems may be at higher risk for experiencing diagnosed memory and thinking impairment decades later. The study is published in the October 28, 2015, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Chemical changes in brain cells caused by disturbances in the body’s day-night cycle may be a key underlying cause of the learning and memory loss associated with Alzheimer’s disease, according to a University of California, Irvine study.
The cost of care over the last five years of life for patients with dementia is significantly higher than for patients who die from heart disease, cancer, or other causes, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai, Dartmouth College and University of California, Los Angeles, and published online today in the journal Annals of Internal Medicine.
Although Lewy Body disease (LBD) is the second-most-common degenerative disease after Alzheimer’s disease (AD), it’s not exactly a household name. A fast, new test can assess clinical signs and symptoms of this disease, and discriminate between AD and LBD with 96
Using 10-year-old archival brain tissue from patients with Alzheimer’s disease, a research team from NYU Langone Medical Center has developed a novel method to examine the structure and function of proteins at the cell level -- providing greater means to study protein changes found in Alzheimer’s disease.
Evidence is mounting that drugs used to treat depression and Alzheimer’s disease also can help patients recover from strokes.
A new study, led by scientists at The Scripps Research Institute, the Veterans Affairs San Diego Healthcare System and University of California San Diego School of Medicine shows that increasing a crucial membrane protein in nerve cells within the brain can improve learning and memory in aged mice.
Researchers find a protein that's involved in helping control the architecture of connections between neurons – a basic process involved in both healthy and diseased brains.
A new and comprehensive study has found that celiac patients are at no increased risk for dementia before or after their diagnosis of celiac disease.
Neural stem cells transplanted into damaged brain sites in mice dramatically improved both motor and cognitive impairments associated with dementia with Lewy bodies, according to University of California, Irvine neurobiologists with the Sue & Bill Gross Stem Cell Research Center and the Institute for Memory Impairments and Neurological Disorders.
The new technique allows scientists to study diseases like Alzheimer’s and Parkinson’s using cells from human patients
The Nantz National Alzheimer Center at Houston Methodist Hospital is part of a landmark clinical trial that looks at removing a key protein from the brain to prevent memory loss at least a decade before symptoms are noticed in healthy older adults.
A multi-institutional team led by scientists at the Indiana University School of Medicine have discovered an immune system gene associated with higher rates of amyloid plaque buildup in the brains of Alzheimer’s patients and older adults at risk for the disease.
Women with a gene variant (APOEe4 allele) associated with Alzheimer’s disease experience a steeper decline in body mass index (BMI) after age 70 than those women without the version of the gene, whether they go on to develop dementia or not.
More than 100 of the world’s leading Alzheimer’s drug researchers will gather today and tomorrow at the Hyatt Regency Jersey City to hear the latest developments in the discovery and testing of promising drugs, detection technologies, biomarkers and newly discovered therapeutic targets for preventing, treating and curing Alzheimer’s disease and related dementias. Organized and hosted by the Alzheimer’s Drug Discovery Foundation, the conference is the only scientific meeting dedicated solely to bringing leading academic and industry scientists together to present new research on Alzheimer’s drug discovery and establish partnerships to further their studies.
Latest Research Highlights from ACSM— September 2015
Clumps of misfolded proteins are responsible for diseases ranging from Huntington’s, to diabetes and Alzheimer’s. McGill researchers hope to incrementally speed up the process of drug discovery for diseases such as these thanks to a new suite of computer tools they have developed.
A new science called Neurogastronomy brings chefs and neuroscientists together to improve quality of life for patients with taste & smell deficits. The inaugural International Society of Neurogastronomy symposium is November 7, 2015, featuring internationally-renowned chefs, scientists, and food technologists.
"This study has let us characterize the parameters of decline in people who will eventually develop Alzheimer's, which means we can better identify both benign symptoms and those that warrant particular attention." - Sylvie Belleville
Alzheimer’s disease, long thought to be a single disease, really consists of three distinct subtypes, according to a UCLA study.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right